For instance, studies with a small number of patients showed that anti-myelin oligodendrocyte glycoprotein (MOG), anti-myelin basic protein (MBP), or anti-KIR4.1 antibodies could serve as a predictor of the development of MS after a first demyelinating event [21,22]. This evidence concerns the gene MOG and myeloid sarcoma.